Hak E - Search Results

1

Monitoring the safety of influenza A (H1N1) vaccine using web-based intensive monitoring.

Härmark L, van Hunsel F, Hak E, van Grootheest K. Härmark L, et al. Among authors: hak e. Vaccine. 2011 Feb 24;29(10):1941-7. doi: 10.1016/j.vaccine.2010.12.123. Epub 2011 Jan 12. Vaccine. 2011. PMID: 21236235 Free article.

2

Design of the Dutch prevention of influenza, surveillance and management (PRISMA) study.

Hak E, van Loon S, Buskens E, van Essen GA, de Bakker D, Tacken MA, van Hout BA, Grobbee DE, Verheij TJ. Hak E, et al. Vaccine. 2003 Apr 2;21(15):1719-24. doi: 10.1016/s0264-410x(02)00520-0. Vaccine. 2003. PMID: 12639495

3

Vaccination of high-risk patients against influenza: impact on primary care contact rates during epidemics. Analysis of routinely collected data.

Tacken MA, Braspenning JC, Berende A, Hak E, De Bakker DH, Groenewegen PP, Grol RP. Tacken MA, et al. Among authors: hak e. Vaccine. 2004 Aug 13;22(23-24):2985-92. doi: 10.1016/j.vaccine.2004.02.017. Vaccine. 2004. PMID: 15297046

4

Negative attitude of highly educated parents and health care workers towards future vaccinations in the Dutch childhood vaccination program.

Hak E, Schönbeck Y, De Melker H, Van Essen GA, Sanders EA. Hak E, et al. Vaccine. 2005 May 2;23(24):3103-7. doi: 10.1016/j.vaccine.2005.01.074. Vaccine. 2005. PMID: 15837208

5

Rationale and design of the prevention of respiratory infections and management in children (PRIMAKid) study: a randomized controlled trial on the effectiveness and costs of combined influenza and pneumococcal vaccination in pre-school children with recurrent respiratory tract infections.

Schönbeck Y, Sanders EA, Hoes AW, Schilder AG, Verheij TJ, Hak E. Schönbeck Y, et al. Among authors: hak e. Vaccine. 2005 Sep 30;23(41):4906-14. doi: 10.1016/j.vaccine.2005.05.021. Vaccine. 2005. PMID: 16005552 Clinical Trial.

6

Do recommended high-risk adults benefit from a first influenza vaccination?

Hak E, Buskens E, Nichol KL, Verheij TJ. Hak E, et al. Vaccine. 2006 Apr 5;24(15):2799-802. doi: 10.1016/j.vaccine.2006.01.008. Epub 2006 Jan 18. Vaccine. 2006. PMID: 16480796 Free article. Clinical Trial.

7

Modelling the health-economic impact of the next influenza pandemic in The Netherlands.

Hak E, Meijboom MJ, Buskens E. Hak E, et al. Vaccine. 2006 Nov 10;24(44-46):6756-60. doi: 10.1016/j.vaccine.2006.05.065. Epub 2006 Jun 9. Vaccine. 2006. PMID: 16797797

8

Attitude of Dutch hospital personnel towards influenza vaccination.

Van den Dool C, Van Strien AM, den Akker IL, Bonten MJ, Sanders EA, Hak E. Van den Dool C, et al. Among authors: hak e. Vaccine. 2008 Mar 4;26(10):1297-302. doi: 10.1016/j.vaccine.2007.12.045. Epub 2008 Jan 18. Vaccine. 2008. PMID: 18262689

9

Decline in influenza-associated mortality among Dutch elderly following the introduction of a nationwide vaccination program.

Jansen AG, Sanders EA, Nichol KL, van Loon AM, Hoes AW, Hak E. Jansen AG, et al. Among authors: hak e. Vaccine. 2008 Oct 16;26(44):5567-74. doi: 10.1016/j.vaccine.2008.08.003. Epub 2008 Aug 21. Vaccine. 2008. PMID: 18722492

10

Determinants of non-compliance with herpes zoster vaccination in the community-dwelling elderly.

Opstelten W, van Essen GA, Hak E. Opstelten W, et al. Among authors: hak e. Vaccine. 2009 Jan 7;27(2):192-6. doi: 10.1016/j.vaccine.2008.10.047. Epub 2008 Nov 7. Vaccine. 2009. PMID: 18996427

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

385 results

Search Page

Filters